Novo Nordisk A/S
CSE:NOVO B
Net Margin
Novo Nordisk A/S
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | DK |
Market Cap | 3.9T DKK |
Net Margin |
37%
|
Country | JP |
Market Cap | 776 550.9T JPY |
Net Margin |
-79%
|
Country | US |
Market Cap | 736.6B USD |
Net Margin |
17%
|
Country | UK |
Market Cap | 440.4B GBP |
Net Margin |
-4%
|
Country | US |
Market Cap | 358.5B USD |
Net Margin |
45%
|
Country | US |
Market Cap | 328.1B USD |
Net Margin |
4%
|
Country | UK |
Market Cap | 190.1B GBP |
Net Margin |
13%
|
Country | CH |
Market Cap | 177.2B CHF |
Net Margin |
20%
|
Country | CH |
Market Cap | 177.1B CHF |
Net Margin |
30%
|
Country | US |
Market Cap | 159.6B USD |
Net Margin |
-1%
|
Country | FR |
Market Cap | 116.7B EUR |
Net Margin |
13%
|
Profitability Report
View the profitability report to see the full profitability analysis for Novo Nordisk A/S.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Novo Nordisk A/S's most recent financial statements, the company has Net Margin of 36.6%.